The Germany Radiotherapy Market was valued at $396.2 Million in 2026 and projected to reach to $477.9 Million by 2031, representing a compound annual growth rate of 4.9%. Germany's radiotherapy market demonstrates resilient growth driven by demographic shifts and healthcare system maturity.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Germany's radiotherapy market is valued at USD 396.2 million in 2026 and is projected to reach USD 477.9 million by 2031, with a CAGR of 4.9%, reflecting steady expansion in advanced cancer treatment adoption.
Germany's robust healthcare system and universal insurance coverage drive consistent investment in radiotherapy technologies, supporting market growth through both public and private healthcare providers.
With an increasingly aging demographic, Germany faces rising cancer incidence rates, creating sustained demand for radiotherapy as a primary treatment modality across oncology centers.
German hospitals and clinics are rapidly adopting precision radiotherapy techniques including IMRT, IGRT, and proton therapy, positioning the country as a leader in advanced treatment delivery.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | ASIA PACIFIC (Application) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6% from 2026 to 2031 |
| Largest Segment | OTHER EBRT APPLICATIONS (Procedure) |
| Market Size Base Year (Billions) | ~USD 7.98 (2026) |
| Revenue Forecast (Billions) | ~USD 10.68 (2031) |
| Segments Covered | Type, System Type, Application, Procedure, End User, Technology |
6 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ADVANCED MEDICAL ISOTOPE CORPORATION | United States | Public Company | IsoPet (veterinary radionuclide therapy),RadioGel and human oncology platforms,PLGA-g-PEG and PrecisionGel polymer platforms, |
| UNILABS | Switzerland | Private Company | Core laboratory testing,Medical imaging,Pathology and centres of excellence, |
| BECTON DICKINSON AND CO | United States | Public Company | Medical Essentials (syringes, needles, catheters, IV sets, sharps disposal),Connected Care & Medication Management (infusion, dispensing, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems), |
| UNITED IMAGING HEALTHCARE CO., LTD. | China | Public Company | CT and MRI systems,Molecular imaging (PET/CT, SPECT),Radiotherapy systems (uRT-linac and ecosystem), |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS), |
| SIEMENS HEALTHINEERS AG | Germany | Public Company | Imaging,Diagnostics,Varian (Oncology), |
| ELEKTA | Sweden | Public Company | Linear accelerators and MR-Linac (Unity, Evo, Versa HD, Harmony, Infinity),Stereotactic radiosurgery (Elekta Esprit gamma knife and neurosurgery systems),Brachytherapy solutions (Elekta Studio, ImagingRing, Oncentra Brachy, Venezia, Flexitron, Geneva, Xoft Axxent), |
| ACCURAY INCORPORATED | United States | Public Company | CyberKnife platform (systems + upgrades + related services),TomoTherapy / Radixact platform (systems + upgrades + related services),Software & data management (iDMS, Accuray Precision, other planning/data tools), |
| HITACHI HIGH-TECH CORPORATION | Japan | Private Company | Analytical & Medical Solutions (microscopes, clinical analyzers, chromatography, spectroscopy),Nano-Technology Solutions (dry etch, CD-SEM, wafer inspection, FIB),Industrial Solutions and ICT (industrial infrastructure, energy, control systems, ICT/IoT), |
| SUMITOMO HEAVY INDUSTRIES, LTD. | Japan | Public Company | Mechatronics (gearmotors, drives, precision positioning, cryogenic equipment),Industrial Machinery (plastics, film forming, semiconductor, medical, defense),Logistics & Construction (excavators, cranes, road and logistics systems), |
| MEVION MEDICAL SYSTEMS | United States | Private Company | Mevion S250i with Hyperscan and Adaptive Aperture,Mevion S250 series (base compact systems),Mevion S250MX multi-room solution, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy (systems and devices),Connected Care & Monitoring (incl. enterprise informatics), |
| SHINVA MEDICAL INSTRUMENT CO., LTD. | China | Public Company | Medical Device Products (infection control, OR integration, radiotherapy, surgical instruments, IVD, dialysis, orthopedic implants),Pharmaceutical Equipment Products (large/small volume injection lines, BFS, freeze dryers, aseptic systems),Medical Trade Products, |
Advanced Medical Isotope Corporation is a publicly traded company established in 1994 that operates in the medical isotope sector in the United States.
Unilabs is a Swiss private company founded in 1987 with 1,897 employees providing laboratory and diagnostic services.
Becton Dickinson and Co is a publicly traded medical technology company founded in 1897 with 72,000 employees, headquartered in the United States.
United Imaging Healthcare Co., Ltd. is a Chinese public company founded in 2011 with 8,703 employees specializing in medical imaging technology.
GE Healthcare is a publicly traded healthcare company established in 2022 with 54,000 employees based in the United States.
Siemens Healthineers AG is a German public company founded in 1896 with 72,369 employees operating in the healthcare technology sector.
Elekta is a Swedish public company founded in 1972 with 3,704 employees specializing in radiation therapy and radiosurgery solutions.
Accuray Incorporated is a publicly traded medical device company founded in 1990 with 990 employees based in the United States.
Hitachi High-Tech Corporation is a Japanese private company founded in 1947 with 11,482 employees providing advanced technology solutions.
Sumitomo Heavy Industries, Ltd. is a Japanese public company founded in 1888 with 25,123 employees operating across multiple industrial sectors.
Mevion Medical Systems is a private medical device company established in 2004 with 165 employees operating in the United States.
Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees operating in healthcare, consumer, and industrial sectors.
Shinva Medical Instrument Co., Ltd. is a Chinese public company founded in 1943 with 7,982 employees specializing in medical instruments.
France's radiotherapy market is estimated at USD 396.2 million in 2026 and is expected to reach USD 477.9 million by 2031.
France's radiotherapy market is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2026 to 2031.
Key growth drivers in France include rising cancer incidence, an aging population, technological advancements in treatment planning, strong government healthcare funding, and improved reimbursement policies.
France maintains a mature radiotherapy market with robust public healthcare infrastructure, widespread technology adoption, and steady growth supported by government investment in oncology services.
France's radiotherapy market is forecasted to reach USD 477.9 million by 2031, representing growth of USD 81.7 million from the 2026 baseline.
This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the radiotherapy market's segments and subsegments. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
The market for companies offering radiotherapy products is derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem and rating them by performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. Secondary research was used to obtain critical information on the industry's value chain, the total pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.
In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data regulation methods, to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted across the entire market engineering process to identify key insights throughout the report.
A breakdown of the primary respondents is provided below:
Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various market segments.
To determine the size of the global radiotherapy market, revenue share analysis was employed with the leading players. In this case, key market players have been identified, and their radiotherapy product business revenues have been determined using insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research included in-depth interviews with key opinion leaders, particularly chief executive officers, directors, and key marketing executives.

After arriving at the overall market size through the market size estimation process described above, the global radiotherapy market was segmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.
The radiotherapy market includes a range of products, solutions, technologies, and services that utilize high-energy radiation for therapeutic purposes. This encompasses various types of radiation, such as X-ray, gamma, electron, and particle radiation. The technologies segment of radiotherapy features systems designed to treat diseases, primarily cancer. This includes external beam radiotherapy methods like LINAC, MRI-LINAC, and cobalt-60 teletherapy. Additionally, internal radiotherapy solutions, commonly known as brachytherapy, are also part of this market segment. Other components of the radiotherapy market include software for imaging and treatment planning. Furthermore, the market provides maintenance and training services related to radiotherapy technologies.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:
Full forecast, segment splits, and company analysis for all Radiotherapy Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report